Overslaan en naar de inhoud gaan

 Alle verbonden artikelen

Corrigendum to Implementation of geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective study" [J. Geriatr. Oncol. 6 (2015) 401-410]."

Auteurs : Baitar A, Kenis C, Moor R, Decoster L, Luce S, Bron D, Van Rijswijk R, Rasschaert M, Langenaeken C, Jerusalem G, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Jaar : 2016
Journal : J Geriatr Oncol
Volume : 7
Pagina's : 142-143

Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study.

Auteurs : Gratwohl A, Iacobelli S, Bootsman N, van Biezen A, Baldomero H, Arcese W, Arnold R, Bron D, Cordonnier C, Ernst P, Ferrant A, Frassoni F, Gahrton G, Richard C, Kolb HJ, Link H, Niederwieser D, Ruutu T, Schattenberg A, Schmitz N, Torres-Gomez A, Zwaan F, Apperley J, Olavarria E, Kröger N
Jaar : 2016
Journal : Ann Hematol
Volume : 95(6)
Pagina's : 967-72

Progression-free survival as surrogate endpoint for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer.

Auteurs : Michiels S, Pugliano L, Marguet S, Grun D, Barinoff J, Cameron D, Cobleigh M, Di Leo A, Johnston S, Gasparini G, Kaufman B, Marty M, Nekjudova V, Paluch-Shimon S, Penault-Llorca F, Slamon D, Vogel C, Von Minckwitz G, Buyse M, Piccart-Gebhart M
Jaar : 2016
Journal : Ann Oncol
Volume : 27(6)
Pagina's : 1029-34

Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.

Auteurs : Kourie HR, Ameye L, Paesmans M, Bron D
Jaar : 2016
Journal : Clin Lymphoma Myeloma Leuk
Volume : 16(5)
Pagina's : 264-8

Mesenchymal stromal cells from the foreskin: Tissue isolation, cell characterization and immunobiological properties.

Auteurs : Najar M, Raicevic G, André T, Fayyad-Kazan H, Pieters K, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : Cytotherapy
Volume : 18
Pagina's : 320-35

The Immunomodulatory Potential of Mesenchymal Stromal Cells: A Story of a Regulatory Network.

Auteurs : Najar M, Raicevic G, Crompot E, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : J Immunother
Volume : 39
Pagina's : 45-59

Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells.

Auteurs : Najar M, Raicevic G, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Jaar : 2016
Journal : Cytotherapy
Volume : 18
Pagina's : 160-71

Improved Treatment of Breast Cancer with Anti-HER2 Therapy Requires Interleukin-21 Signaling in CD8+ T Cells.

Auteurs : Mittal D, Caramia F, Michiels S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Loi S, Smyth MJ
Jaar : 2016
Journal : Cancer Res
Volume : 76
Pagina's : 264-74

Onco-haematology geriatry : impact of cognitive disorders.

Auteurs : Dubruille S, Libert Y, Razavi D, Bron D
Jaar : 2016
Journal : Belgian J Hematology
Volume : 7
Pagina's : 180-3

Belgium recommendations for the management of acute promyelocytic leukaemia

Auteurs : Wittnebel S
Jaar : 2016
Journal : Belgian J Hematology
Volume : 7
Pagina's : 224-8

BHS guidelines for the treatment of large granular lymphocyte and cronic prolymphocytic leukaemias

Auteurs : Delrieu V, Wu KL, Schroyens W, Bonnet C, Bron D, Janssens A
Jaar : 2016
Journal : Belgian J Hematology
Volume : 7
Pagina's : 103-11

The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.

Auteurs : Ignatiadis M, Azim HA Jr, Desmedt C, Veys I, Larsimont D, Salgado R, Lyng MB, Viale G, Leyland-Jones B, Giobbie-Hurder A, Kammler R, Dell orto P, Rothé F, Laïos I, Ditzel HJ, Regan MM, Piccart-Gebhart M, Michiels S, Sotiriou C
Jaar : 2016
Journal : JAMA Oncol
Volume : 2(2)
Pagina's : 217-24

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.

Auteurs : Van Damme M, Crompot E, Meuleman N, Maerevoet M, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Jaar : 2016
Journal : Clin Epigenetics
Volume : 8
Pagina's : 132

The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor gene.

Auteurs : Van Kempen LC, Redpath M, Elchebly M, Klein KO, Papadakis AI, Wilmott JS, Scolyer RA, Edqvist PH, Pontén F, Schadendorf D, van Rijk AF, Michiels S, Dumay A, Helbling-Leclerc A, Dessen P, Wouters J, Stass M, Greenwood CM, Ghanem G, van den Oord J, Feunteun J, Spatz A
Jaar : 2016
Journal : Sci Transl Med
Volume : 8
Pagina's : 369ra177

Access to human tissues for research and product development: From EU regulation to alarming legal developments in Belgium.

Auteurs : Pirnay JP, Baudoux E, Cornu O, Delforge A, Delloye C, Guns J, Heinen E, Van den Abbeel E, Vanderkelen A, Van Geyt C, van Riet I, Verbeken G, De Sutter P, Verlinden M, Huys I, Cockbain J, Chabannon C, Dierickx K, Schotsmans P, De Vos D, Rose T, Jennes S, Sterckx S
Jaar : 2015
Journal : EMBO Rep.
Volume : 16(5)
Pagina's : 557-62

Aging and blood disorders: new perspectives, new challenges.

Auteurs : Bron D, Ades L, Fulop T, Goede V, Stauder R
Jaar : 2015
Journal : Haematologica
Volume : 100(4)
Pagina's : 415-7

NFAT-1, Sp-1, Sp-3, and miR-21: New regulators of chemokine C receptor 7 expression in mature human dendritic cells.

Auteurs : Al Akoum C, Akl I, Rouas R, Fayyad-Kazan M, Falha L, Renno T, Burny A, Lewalle P, Fayyad-Kazan H, Badran B
Jaar : 2015
Journal : Hum Immunol
Volume : 76(5)
Pagina's : 307-17

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.

Auteurs : Muylle K, Flamen P, Vugts DJ, Guiot T, Ghanem G, Meuleman N, Bourgeois P, Vanderlinden B, van Dongen GA, Everaert H, Vaes M, Bron D
Jaar : 2015
Journal : Eur J Nucl Med Mol Imaging
Volume : 42(8)
Pagina's : 1304-14

In honor of Professor Philippe Martiat

Auteurs : Bron D, Lewalle P
Jaar : 2015
Journal : Rev Med Brux
Volume : 36(1)
Pagina's : 58-9

Opposite prognostic significance of cellular and serum circulating microRNA-150 in Chronic Lymphocytic Leukemia patients.

Auteurs : Stamatopoulos B, Van Damme M, Crompot E, Dessars B, El Housni H, Mineur P, Meuleman N, Bron D, Lagneaux L
Jaar : 2015
Journal : Mol. Med.
Volume : 21(1)
Pagina's : 123-33